What J&J Gets Out Of JLABS Incubators
Kara Bortone, head of Johnson & Johnson Innovation's JLABS site in San Diego and interim head of the group's newest incubator site in Belgium, on the benefits of JLABS for the companies involved and the big pharma itself.
You may also be interested in...
It is time for In Vivo's 13th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2020. Data provided by Biomedtracker.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.